Items where authors include "Wilcox, M."

Article

Woods, B. orcid.org/0000-0002-7669-9415, Kearns, B., Schmitt, L. et al. (15 more authors) (2025) Assessing the value of new antimicrobials: evaluations of cefiderocol and ceftazidime-avibactam to inform delinked payments by the NHS in England. Applied Health Economics and Health Policy, 23 (1). pp. 5-17. ISSN 1175-5652

Freeman, J., Viprey, V. orcid.org/0000-0001-6463-7092, Ewin, D. et al. (10 more authors) (2024) Antimicrobial susceptibility in Clostridioides difficile varies according to European region and isolate source. JAC-Antimicrobial Resistance, 6 (4). dlae112. ISSN 2632-1823

Wu, Y. orcid.org/0000-0003-4080-3935, Biswas, D. orcid.org/0000-0001-9141-5188, Usaite, I. et al. (302 more authors) (2022) A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nature Cancer, 3. pp. 696-709. ISSN 2662-1347

Normington, C., Moura, I. orcid.org/0000-0002-3019-7196, Byrant, J. et al. (4 more authors) (2022) Sessile Clostridioides difficilecontribute towards recurrent C. difficileinfection. Access Microbiology, 4 (5). ISSN 2516-8290

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

Conference or Workshop Item

Beauchemin, N., Halvorsen, E., Hicks, N. et al. (20 more authors) (2025) Characterization of IBD microbiomes in models of microbiome disruption and inflammation to evaluate candidate biomarkers for patient selection. In: DDW 2025, 03-06 May 2025, San Diego, California, United States.

Proceedings Paper

Beauchemin, N., Halvorsen, E., Hicks, N. et al. (20 more authors) (2025) Sa1770: CHARACTERIZATION OF IBD MICROBIOMES IN MODELS OF MICROBIOME DISRUPTION AND INFLAMMATION TO EVALUATE CANDIDATE BIOMARKERS FOR PATIENT SELECTION. In: Gastroenterology. DDW 2025, 03-06 May 2025, San Diego, USA. Elsevier , S-523-S-523.